Cardioprotective effects of yellowstripe scad compared to salmon among healthy overweight adults in a randomized crossover trial
Fish intake may be cardioprotective, with omega-3 fatty acid as the possible major contributing nutrient. However, intervention study determining the cardioprotective effects of omega-3 rich fish is scarce. It is unclear whether yellowstripe scad (YSS) as compared with salmon, both rich in omega-...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2019
|
| Subjects: | |
| Online Access: | http://psasir.upm.edu.my/id/eprint/79352/1/FPSK%28m%29%202019%205%20ir.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Fish intake may be cardioprotective, with omega-3 fatty acid as the possible major
contributing nutrient. However, intervention study determining the cardioprotective
effects of omega-3 rich fish is scarce. It is unclear whether yellowstripe scad (YSS) as
compared with salmon, both rich in omega-3 fatty acids, have effects on cardiovascular
disease (CVD) risk factors. The objective of this study was to compare the effects of
YSS and salmon on selected CVD risk factors among healthy overweight adults. A
randomized crossover trial with two diet periods was conducted among healthy
overweight (with BMI 23.0-27.4 kg/m2) Malaysian adults aged 21-55 years. Steamed
whole YSS fish or salmon fillet was given for eight weeks (3 days per week), retaining
approximately 1000 mg eicosapentaenoic acid and docosahexaenoic acid (EPA+DHA)
per day. Diets were switched after an 8-week washout period. Fasting blood samples
were collected before and after each diet period. Biochemical changes in serum and
plasma were analysed. About 98 subjects were screened for eligibility and 49 subjects
were participated in the intervention (35% male and 65% female; mean age 29±7 years).
Results showed that P-selectin and erythrocyte sedimentation rate (ESR) were
significantly reduced from baseline following the consumption of YSS (-13.024% and -
14.76% respectively, p< .05). Conversely, salmon group had significant improvement
on lipid profile [triglycerides (-15.09%), HDL-cholesterol (+3.85%), and VLDLcholesterol
(-14.58%)] and inflammatory cytokines [IL-6 (-5.88%) and TNF-α
(-2.19%)] (p< .05). Uric acid was increased significantly by salmon diet from 0.32±0.10
mmol/L to 0.35±0.09 mmol/L (p< .05). Greater favourable effects on triglycerides (0.09
mmol/L, 95% CI=0.06-0.22, p= .01), VLDL-cholesterol (0.04 mmol/L, 95% CI=0.03-
0.11, p= .01), and IL-6 (0.01 pg/ml, 95% CI=-0.04-0.07, p= .03) were noted in salmon
group as compared with YSS. These outcomes demonstrated that short-term
consumption of salmon showed more pronounced effect on lipid profile and
inflammatory factors as compared with YSS. Nevertheless, the favourable changes on
haematological factors exerted by YSS group might deserve same attention. The beneficial effects of YSS and salmon on selected cardiovascular risk factors were
unlikely to be similar despite their comparable EPA+DHA content. |
|---|